199 related articles for article (PubMed ID: 17363734)
41. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
42. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
[TBL] [Abstract][Full Text] [Related]
43. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
Soejima K; Rollins BJ
J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
[TBL] [Abstract][Full Text] [Related]
44. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
45. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
46. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
47. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
[TBL] [Abstract][Full Text] [Related]
48. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation.
Ebert LM; McColl SR
J Immunol; 2001 Apr; 166(8):4870-8. PubMed ID: 11290763
[TBL] [Abstract][Full Text] [Related]
49. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
[TBL] [Abstract][Full Text] [Related]
50. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
Marx N; Mach F; Sauty A; Leung JH; Sarafi MN; Ransohoff RM; Libby P; Plutzky J; Luster AD
J Immunol; 2000 Jun; 164(12):6503-8. PubMed ID: 10843708
[TBL] [Abstract][Full Text] [Related]
51. Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines.
Miekus K; Jarocha D; Trzyna E; Majka M
Folia Histochem Cytobiol; 2010 Jan; 48(1):104-11. PubMed ID: 20529825
[TBL] [Abstract][Full Text] [Related]
52. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat.
Poggi A; Carosio R; Fenoglio D; Brenci S; Murdaca G; Setti M; Indiveri F; Scabini S; Ferrero E; Zocchi MR
Blood; 2004 Mar; 103(6):2205-13. PubMed ID: 14630801
[TBL] [Abstract][Full Text] [Related]
53. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection.
Neusser MA; Kraus AK; Regele H; Cohen CD; Fehr T; Kerjaschki D; Wüthrich RP; Penfold ME; Schall T; Segerer S
Kidney Int; 2010 May; 77(9):801-8. PubMed ID: 20164826
[TBL] [Abstract][Full Text] [Related]
54. The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection.
Torraca V; Cui C; Boland R; Bebelman JP; van der Sar AM; Smit MJ; Siderius M; Spaink HP; Meijer AH
Dis Model Mech; 2015 Mar; 8(3):253-69. PubMed ID: 25573892
[TBL] [Abstract][Full Text] [Related]
55. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor.
Yates CC; Whaley D; Kulasekeran P; Hancock WW; Lu B; Bodnar R; Newsome J; Hebda PA; Wells A
Am J Pathol; 2007 Aug; 171(2):484-95. PubMed ID: 17600132
[TBL] [Abstract][Full Text] [Related]
56. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
57. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
Tensen CP; Flier J; Van Der Raaij-Helmer EM; Sampat-Sardjoepersad S; Van Der Schors RC; Leurs R; Scheper RJ; Boorsma DM; Willemze R
J Invest Dermatol; 1999 May; 112(5):716-22. PubMed ID: 10233762
[TBL] [Abstract][Full Text] [Related]
58. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.
Schutyser E; Su Y; Yu Y; Gouwy M; Zaja-Milatovic S; Van Damme J; Richmond A
Eur Cytokine Netw; 2007 Jun; 18(2):59-70. PubMed ID: 17594938
[TBL] [Abstract][Full Text] [Related]
59. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S
Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061
[TBL] [Abstract][Full Text] [Related]
60. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
